Value and the cost of medicines working together for a sustainable health-care system

Often missing from these conversations is the value that innovative medicines bring to the health-care system and to patients.

Through improved dialogue and increased collaboration, the innovative pharmaceutical industry, public and private payers, government agencies, healthcare providers and patients, can arrive at a strong, sustainable vision for healthcare in Canada, writes Chris Halyk.

PUBLISHED :Monday, June 27, 2016 12:00 AM

If you are already a subscriber

Subscribe to The Hill Times

Subscribe to the digital and/or print editions and get instant access to The Hill Times online.

Quick Purchase

Purchase Story Issue in electronic format (PDF) for $5.00.